First Page | Document Content | |
---|---|---|
![]() Date: 2011-05-03 08:41:47Selective estrogen receptor modulators Alkenes Prodrugs Tamoxifen Breast cancer Endometrial cancer Antiestrogen Cancer Adjuvant therapy Medicine AstraZeneca Aromatase inhibitors | Source URL: www.iss.itDownload Document from Source WebsiteFile Size: 143,18 KBShare Document on Facebook |
![]() | Award ID: DP150096 Project Title: ESR1 Coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy resistant metastatic breast cancer Award Mechanism:DocID: 1aiKa - View Document |
![]() | References for Substances Tested in the In Vitro ER Binding Assays: Appx D2 - ICCVAM ER Binding BRD (NIH Publication No[removed])DocID: RQPw - View Document |
![]() | ACOG COMMITTEE OPINION Number 412 • August 2008 Aromatase Inhibitors in Gynecologic Practice Committee onDocID: PTgx - View Document |
![]() | Shift work and adverse health effects: possible biological mechanismsDocID: G8Xf - View Document |
![]() | Endocrine Disruptor Screening and Testing Advisory Committee Final Report - Appendix JDocID: A3xU - View Document |